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ABSTRACT                        Lysosomal acid hydrolases play an imperative part in the initiation of inflam-
mation processes associated with myocardial infarction. In the present investigation, we have 
studied the protective effect of L-glutamine on isoproterenol-induced myocardial damage in 
male albino rats with respect to alterations in lysosomal function. The myocardial infarction 
in experimental animals was induced by intraperitoneal (i.p.) injection of isoproterenol (11 
mg/100 g body weight/day) for 2 days. The total and free activities of lysosomal acid hydrolases 
(β-glucuronidase, β-galactosidase, β-glucosidase and acid phosphatase) were determined in 
plasma and heart tissue of control and treated rats. Significant elevation in the total activities 
of lysosomal hydrolases was observed in plasma and heart tissue of isoproterenol administered 
rats. A parallel (p<0.05) rise in the free activities of these acid hydrolases in the cardiac tissue 
was also noticed. Isoproterenol-mediated lysosomal membrane fragility was evident from the 
altered subcellular distribution of heart β-glucuronidase activity. Prior oral administration of 
L-glutamine (100 mg/kg body weight/day for a period of 20 days) significantly attenuated the 
isoproterenol-induced release of these lysosomal hydrolases into the systemic circulation from 
the cardiac lysosomes and maintained the lysosomal stability at level comparable to that of 
control rats. The results of the present study suggested that the cardioprotective activity of 
glutamine might be related to its membrane-stabilizing property.
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Introduction
Despite extensive advances in diagnosis and management 
over the last three decades, acute myocardial infarction con-
tinues to be a major public health problem (Boden 2003). 
A considerable body of experimental proof is now evolving 
which proposes that atypical discharge of lysosomal hydro-
lases plays a major role in the pathogenesis of myocardial in-
farction (Punithavathi and Prince 2010). Scientific knowledge 
on the events occurring in myocardial infarction condition 
has moved the cardiovascular research towards biomolecules, 
which can attenuate the incidence of myocardial ischemia. 
The efficacy of several cytoprotective agents on the preven-
tion of necrotic injury connected with tissue damage has been 
accredited to their ability to preserve lysosomal integrity and 
to block the discharge of the lysosomal hydrolases (Jayachan-
dran et al. 2009).
L-Glutamine is the most prevalent free proteinogenic 
aminoacid in many organs, including heart. Glutamine, 
traditionally considered a nonessential amino acid, now is 
considered “conditionally essential” after critical illness, 
stress, and injury. It plays an important role in the inter-organ 
nitrogen exchange and the maintenance of pH homeostasis 
(van de Poll et al. 2004). It is one of the major constituents of 
proteins and it functions as a chief metabolite in amino acid 
transamination reactions via α-ketoglutarate and glutamate. 
It delivers nitrogen for numeral biosynthetic pathways by 
serving as a major precursor of the purine and pyrimidine 
rings of nucleic acids and nucleotides including adenosine 
triphosphate (ATP) (Mora et al. 2002). It is used as an energy 
substrate in most cells, including heart myocytes (Suleiman 
et al. 1997). It is also involved in the regulation of endothelial 
nitric oxide metabolism in the cardiac tissue (Murphy and 
Newsholme 1998). Glutamine plays a vital part in reduced 
glutathione biosynthesis by providing glutamate to the glu-
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tathione antioxidant defense system (Roth 2008). Pisarenko 
and co-workers (1983) reported decline in the intracellular 
concentration of glutamine in the cardiac tissue during myo-
cardial dysfunction. Even though glutamine is participating 
in numerous key biological and physiological functions in 
the myocardium; the cardioprotective activity of glutamine 
on lysosomal function in isoproterenol-induced myocardial 
infarction has not been studied in detail.
Isoproterenol [L-1-(3,4-dihydroxyphenyl)-2-isopropylam-
inoethanol hydrochloride], a β-adrenergic agonist, induces 
many morphologic and metabolic alterations in the heart tis-
sue of experimental rats similar to those seen in myocardial 
infarction in man (Sathish et al. 2003; Anandan et al. 2013). 
It induces myocardial necrosis by a multiple step mechanism. 
It acts through β-adrenergic receptors, stimulating calcium 
influx, and augmenting the consumption of oxygen and deple-
tion of ATP (Wallis et al. 2001). Lysosomal hydrolases play 
a major role in the pathogenesis of isoproterenol-induced 
myocardial infarction (Nirmala and Puvanakrishnan 1996). 
Alterations in lysosomal integrity and the activities of car-
diac lysosomal hydrolases (β-glucuronidase, β-glucosidase, 
β-galactosidase and acid phosphatase) have been reported in 
isoproterenol-induced myocardial infarction (Prince and Priya 
2010). One of the characteristic features of isoproterenol-
induced myocardial infarction in experimental animals is 
the link between the progression of inflammatory responses 
and the extent of liberation of lysosomal hydrolases from 
the necrotic tissue into the systemic circulation (Ebenezer 
et al. 2003). 
In this study, we have investigated the protective effect of 
L-glutamine on lysosomal function in isoproterenol-induced 
myocardial infarction in rats by virtue of its antioxidant 
(Marques et al. 2011) and membrane stabilizing properties 
(Anandan et al. 2013).
Materials and Methods
Chemicals
L-Glutamine, isoproterenol, p-nitrophenol, p-nitrophenyl 
β-D-galactopyranoside and p-nitrophenol-β-glucuronide were 
procured from Sigma (St. Louis. MO, USA). All the other 
chemicals used were of analytical grade.
Animals
Wistar strain male albino rats, weighing 120-150 g were used 
for the study. Animals were kept individually in polyurethane 
cages under hygienic and maintained standard environmen-
tal conditions (28±2 °C; humidity 60-70%; 12 h light/dark 
cycle). The control and treated rats were allowed free access 
to food (Sai Feeds, Bangalore, India) and water. The guide-
lines prescribed by the Committee for the Purpose of Control 
and Supervision of Experiments on Animals (CPCSEA; New 
Delhi, India) with the approval of Institutional Animal Eth-
ics Committee (IAEC) were strictly followed during animal 
experiments.
Experimental protocol
The animals were divided into four groups, comprising six 
rats each. 
Group I: Normal control rats received standard pelleted 
diet and intragastrically administered with distilled water 
for a period of 20 days and then injected with physiological 
saline alone for 2 days.
Group II: Rats intragastrically administered with L-
glutamine (100 mg/kg body weight/day; dissolved in distilled 
water) for a period of 20 days and then injected with physi-
ological saline alone for 2 days.
Group III: Rats administered with distilled water for a 
period of 20 days and then injected with isoproterenol (11 
mg/100 g body weight/day dissolved in physiological saline, 
i.p. for 2 days for the induction of myocardial infarction.
Group IV: Rats pretreated with glutamine (100 mg/kg 
body weight/day, p.o for 20 days before the induction of 
myocardial infarction as described for Group III.
At the end of the experimental period (i.e. 24 h after last 
injection of isoproterenol), the control and treated rats were 
killed and blood was collected using EDTA as anticoagulant 
for the separation of plasma. 
Separation of subcellular fractions 
The hearts excised were immediately cut open and kept in 
isotonic saline to remove the blood. Then cardiac tissue 
samples were homogenized in 0.25 M ice-cold sucrose solu-
tion (0.5 g tissue/5 ml) at 4 °C. The plasma and a portion of 
myocardial homogenate were used for the determination of 
the total activity of lysosomal enzymes. The total activity in 
heart tissue referred to that detected in the 800 g supernatant 
fraction in the presence of 0.2% (v/v) Triton X-100, while 
the free activity referred to that detected in the 15 000 g 
supernatant without Triton X-100.
The remaining tissue homogenate portions were subjected 
to differential centrifugation and the different fractions were 
obtained as follows: 
a) structural proteins, nucleus, and cell debris at 600 g 
for 10 min; 
b) mitochondria at 5 000 g for 10 min; 
c) lysosomes at 15 000 g for 10 min; 
The nuclear and lysosomal fractions were then treated 
with Triton X-100 (final concentration 0.2% v/v) at 4 °C for 
15 min just prior to the determination of enzyme activities.
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Assay of lysosomal enzymes
The activities of β-glucuronidase and cathepsin D were de-
termined according to the experimental procedures described 
by Devlin and Gianetto (1970) and Sapolsky et al. (1973), 
respectively. β-galactosidase and β-N-acetyl glucosamini-
dase were estimated by the method of Rosenblit et al. (1974) 
and acid phosphatase according to the procedure of King 
(1965). The subcellular localization (nuclear and lysosomal 
fraction) of β-glucuronidase was determined as a measure 
of lysosomal stability. The activities of β-glucuronidase, 
β-galactosidase and β-N-acetylglucosaminidase were mea-
sured as x10-2 µmoles of p-nitrophenol formed/h/mg protein. 
The cathepsin D activity was expressed as x10-3 µmoles of 
tyrosine liberated/h/mg protein. The acid phosphatase activ-
ity was quantified as x10-2 µmoles of phenol formed/min/
mg protein.
Statistical analysis
Results are expressed as mean ± SD (standard deviation) for 
6 animals. Multiple comparisons of the significant analysis 
of variance were performed by Duncan’s multiple range com-
parison test. A P-value <0.05 was considered as statistically 
significant. All data were analyzed with the help of statistical 
package program, SPSS 10.0 for Windows.
Results and discussion
Activities of total lysosomal hydrolases in plasma and heart 
tissue of control and treated rats are depicted in Table 1 and 
Table 2. In the present study, injection of isoproterenol re-
sulted in a significant (p<0.05) elevation in the total activities 
of lysosomal enzymes (acid phosphatase, β-D glucosidase 
and β-D-galactosidase) in plasma and heart tissue of Group 
III rats compared to Group I control animals. A concomitant 
(p<0.05) rise in the free activities of these enzymes in the 
heart tissue was also noticed (Table 3). This is in agreement 
with an earlier report (Sathish et al. 2003). The observed 
cardiac lysosome fragility and increase in systemic acid 
hydrolases implies that outflow or extrusion of lysosomal 
hydrolases might be associated with stimulated endocytic 
processes harmful to cellular and subcellular membranes 
(Punithavathi and Prince 2010; Sathish et al. 2003). The rate 
of release of lysosomal specific β-glucuronidase is an index 
of lysosomal integrity. The altered subcellular distribution 
of β-glucuronidase in the heart tissue of isoproterenol-
administered rats is an indication of instability of cardiac 
lysosomes (Table 4). The increased total and free activities of 
lysosomal acid hydrolases in the heart tissue of Group III rats 
confirms the increased expression of lysosomal hydrolases in 
isoproterenol-induced myocardial infarction.
Table 1. Total activity of lysosomal hydrolases (β-glucuronidase, β-galactosidase, β-N-acetyl glucosaminidase, acid phosphatase and 
cathepsin D) in plasma of control and treated groups of rats.
Parameters Group I Group II Group III Group IV
β-glucuronidase 2.50±0.15a 2.43±0.17 a 9.34±0.85 b 3.76±0.22c
β-galactosidase 1.42±0.09a,c 1.35±0.11 a 3.56±0.25 b 1.69±0.14 c
β-N-acetyl glucosaminidase 2.29±0.17a 2.34±0.15 a 3.89±0.21b 2.72±0.16c
acid phosphatase 1.56±0.12a,c 1.43±0.14 a 3.93±0.31 b 1.85±0.18c
cathepsin D 7.31±0.56a 7.18±0.61 a 21.4±0.19 b 10.25±0.92 c
Values that have a different superscript letter (a,b,c) differ significantly (p<0.05) with each other.
Table 2. Total activity of lysosomal hydrolases (β-glucuronidase, β-galactosidase, β-N-acetyl glucosaminidase, acid phosphatase and 
cathepsin D) in heart tissue of control and treated groups of rats.
Parameters Group I Group II Group III Group IV
β-glucuronidase 29.42±1.72a 27.36±1.61 a 39.25±2.38 b 31.01±1.99 a
β-galactosidase 9.36±0.69a 9.10±0.62 a 14.78±1.01 b 9.93±0.76 a
β-N-acetyl glucosaminidase 12.79±0.85 a 10.92±0.78 b 18.0±1.02 c 14.3±0.81 a
acid phosphatase 4.15±0.32 a 4.23±0.26 a 5.85±0.37 b 4.27±0.21 a
cathepsin D 19.36±1.57a 19.45±1.49 a 34.82±2.18 b 22.38±1.74 a
Values that have a different superscript letter (a,b,c) differ significantly (p<0.05) with each other.
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In Group IV animals, the administration of L-glutamine 
significantly inhibited the liberation of lysosomal hydrolases 
into the systemic circulation from the heart tissue. Glutamine 
might have exerted its protective actions either by modulat-
ing the lysosomal stability or by blocking the discharge of 
lysosomal hydrolases. Antioxidant defense of glutamine 
may protect the lysosomal membrane from isoproterenol-
mediated reactive free radical species through the formation 
of reduced glutathione, which plays a major role in preserv-
ing the structural and functional integrity of the cellular and 
subcellular membranes (Roth 2008). Studies by Kadowaki 
and Kanazawa (2003) have shown that excess glutamine at 
tenfold the plasma level has an abnormal inhibitory effect on 
hepatic proteolysis, due to a lysosomotropic toxicity of am-
monia derived from glutamine degradation. This amino acid 
is recognized at the plasma membrane, indicating the possible 
existence of glutamine receptor/sensor for its recognition and 
subsequent intracellular signaling. Investigations by Pourah-
mad and co-workers (2005) have indicated that glutamine 
administration attenuates the lysosomal hydrolases-mediated 
chromate cytotoxicity by acting as protease inhibitor and/or 
reactive oxygen species (ROS) scavenger. 
Reports by Li and co-workers (2003) has indicated that 
adding a limited amount of glutamine to the freezing media 
is beneficial in maintaining the membrane and acrosome in-
tegrity in cryopreservation of cynomolgus monkey (Macaca 
fascicularis) sperm. Studies by Bergamini et al. (1993) have 
demonstrated the inhibitory activity of glutamine on macroau-
tophagy and proteolytic function in liver of Sprague-Dawley 
albino rats with the use of the antilipolytic agent 3,5’-dime-
thylpyrazole as a stimulatory agent. Investigations by Pösö 
and co-workers (1987) have shown that glutamine and ethanol 
synergistically attenuate protein degradation in the liver by 
two discrete mechanisms: one decreasing the formation of 
autophagic vacuoles and the other involving lysosomotropic 
inhibition, possibly via ammonia. Studies by Mortimore and 
Pösö (1984) have indicated that of all the amino acids only 
glutamine directly exerts inhibitory activity on lysosomal 
pathways in hepatic protein degradation.
Conclusion
In conclusion, the results of the present investigation have 
demonstrated that glutamine possibly exerted its cardioprotec-
tive action through modulating structural and functional integ-
rity of myocardial lysosomes. However, further investigations 
are essential to confirm the exact molecular mechanism of 
glutamine involved in the lysosomal membrane-stabilizing 
activity reported in this study.
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